Flash Forward is a show about possible (and not so possible) future scenarios. What would the warranty on a sex robot look like? How would diplomacy work if we couldn’t lie? Could there ever be a fecal transplant black market? (Complicated, it wouldn’t, and yes, respectively, in case you’re curious.) Hosted and produced by award winning science journalist Rose Eveleth, each episode combines audio drama and journalism to go deep on potential tomorrows, and uncovers what those futures might re ...
…
continue reading
Inhoud geleverd door Dr Neil Love. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Dr Neil Love of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Player FM - Podcast-app
Ga offline met de app Player FM !
Ga offline met de app Player FM !
Breast Cancer | Oncology Today with Dr Neil Love: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
MP4•Thuis aflevering
Manage episode 435464008 series 1464352
Inhoud geleverd door Dr Neil Love. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Dr Neil Love of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Featuring perspectives from Dr Sara A Hurvitz, including the following topics:
- Case: A woman in her late 40s who received treatment for triple-negative breast cancer develops lung metastases 2 years later (0:00)
- Clinical trials investigating TROP2-targeting antibody-drug conjugates (13:28)
- Identifying and targeting HER2 in HER2 low-expressing disease (21:17)
- Case: A woman in her early 50s who received treatment for Stage I breast cancer later develops multiple lesions similar to the original cancer (29:00)
- Thresholds of HER2 expression and the efficacy of trastuzumab deruxtecan (T-DXd) (34:01)
- Case: A woman in her late 50s receiving T-DXd for HER2-low metastatic breast cancer develops asymptomatic ground glass infiltrates in the lung (39:19)
- Novel ADC strategies under investigation (48:22)
1423 afleveringen
MP4•Thuis aflevering
Manage episode 435464008 series 1464352
Inhoud geleverd door Dr Neil Love. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Dr Neil Love of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Featuring perspectives from Dr Sara A Hurvitz, including the following topics:
- Case: A woman in her late 40s who received treatment for triple-negative breast cancer develops lung metastases 2 years later (0:00)
- Clinical trials investigating TROP2-targeting antibody-drug conjugates (13:28)
- Identifying and targeting HER2 in HER2 low-expressing disease (21:17)
- Case: A woman in her early 50s who received treatment for Stage I breast cancer later develops multiple lesions similar to the original cancer (29:00)
- Thresholds of HER2 expression and the efficacy of trastuzumab deruxtecan (T-DXd) (34:01)
- Case: A woman in her late 50s receiving T-DXd for HER2-low metastatic breast cancer develops asymptomatic ground glass infiltrates in the lung (39:19)
- Novel ADC strategies under investigation (48:22)
1423 afleveringen
Todos os episódios
×Welkom op Player FM!
Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.